CO2022019089A2 - Anticuerpos de conejo contra inmunoglobulinas g humanas - Google Patents

Anticuerpos de conejo contra inmunoglobulinas g humanas

Info

Publication number
CO2022019089A2
CO2022019089A2 CONC2022/0019089A CO2022019089A CO2022019089A2 CO 2022019089 A2 CO2022019089 A2 CO 2022019089A2 CO 2022019089 A CO2022019089 A CO 2022019089A CO 2022019089 A2 CO2022019089 A2 CO 2022019089A2
Authority
CO
Colombia
Prior art keywords
antibodies against
human immunoglobulin
against human
rabbit antibodies
antibodies
Prior art date
Application number
CONC2022/0019089A
Other languages
English (en)
Inventor
Ruiyin Chu
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of CO2022019089A2 publication Critical patent/CO2022019089A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente descripción se refiere a anticuerpos anti-IgG humana y porciones de unión al antígeno de los mismos derivados de conejos y a métodos de uso de estos anticuerpos y porciones.
CONC2022/0019089A 2020-06-01 2022-12-28 Anticuerpos de conejo contra inmunoglobulinas g humanas CO2022019089A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063033073P 2020-06-01 2020-06-01
PCT/US2021/035264 WO2021247588A2 (en) 2020-06-01 2021-06-01 Rabbit antibodies to human immunoglobulins g

Publications (1)

Publication Number Publication Date
CO2022019089A2 true CO2022019089A2 (es) 2022-12-30

Family

ID=76859716

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0019089A CO2022019089A2 (es) 2020-06-01 2022-12-28 Anticuerpos de conejo contra inmunoglobulinas g humanas

Country Status (14)

Country Link
US (1) US20210380719A1 (es)
EP (1) EP4157870A2 (es)
JP (1) JP2023532412A (es)
KR (1) KR20230018478A (es)
CN (1) CN115698061A (es)
AR (1) AR122498A1 (es)
AU (1) AU2021283192A1 (es)
BR (1) BR112022023904A2 (es)
CA (1) CA3184763A1 (es)
CO (1) CO2022019089A2 (es)
IL (1) IL298621A (es)
MX (1) MX2022015236A (es)
TW (1) TW202210525A (es)
WO (1) WO2021247588A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115819578B (zh) * 2022-10-29 2023-08-18 武汉爱博泰克生物科技有限公司 高亲和力Human IL-5兔单克隆抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142374A1 (en) 1998-08-17 2002-10-03 Michael Gallo Generation of modified molecules with increased serum half-lives
WO2011137388A2 (en) * 2010-04-30 2011-11-03 Fred Hutchinson Cancer Research Center Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample

Also Published As

Publication number Publication date
BR112022023904A2 (pt) 2022-12-27
CA3184763A1 (en) 2021-12-09
EP4157870A2 (en) 2023-04-05
AR122498A1 (es) 2022-09-14
TW202210525A (zh) 2022-03-16
WO2021247588A3 (en) 2022-02-17
JP2023532412A (ja) 2023-07-28
WO2021247588A2 (en) 2021-12-09
CN115698061A (zh) 2023-02-03
KR20230018478A (ko) 2023-02-07
US20210380719A1 (en) 2021-12-09
AU2021283192A1 (en) 2023-02-09
MX2022015236A (es) 2023-01-11
IL298621A (en) 2023-01-01

Similar Documents

Publication Publication Date Title
CO2022019089A2 (es) Anticuerpos de conejo contra inmunoglobulinas g humanas
ECSP20076683A (es) Anticuerpos frente a entpd2, terapias de combinación y métodos de uso de los anticuerpos y las terapias de combinación
CR20150095A (es) Proteinas de unión a antígeno capaces de unirse a linfopoyetina estromática tímica
CO2019012356A2 (es) Formulaciones estables de anticuerpos anti-tigit solos y en combinación con anticuerpos receptores de muerte programada 1 (pd-1) y métodos para su uso
BR112021012027A2 (pt) Molécula bifuncional direcionada contra pd-1 humano
CU24648B1 (es) Conjugados de fármacos y anticuerpos anti-ccr7
WO2009129538A3 (en) Human equivalent monoclonal antibodies engineered from nonhuman variable regions
CR11030A (es) Proteinas de union, incluyendo anticuerpos, derivados de anticuerpos y fragmentos de anticuerpos, que se unen especificamente a cd154 y sus usos
AR077630A1 (es) Polipeptidos y metodo de tratamiento
MA35711B1 (fr) Anticorps anti-alphabêtatcr
ATE487946T1 (de) Analytischer sandwichtest zur bestimmung von nt- probnp
MX2020013606A (es) Constructos de anticuerpos multiespecificos.
CR20210628A (es) Fragmentos de unión al antígeno cd3 y composiciones que comprenden los mismos
ECSP22055004A (es) Anticuerpos anti?mertk y m?todos de uso de los mismos
UY39798A (es) Anticuerpos anti-ccr8 y usos de los mismos
IL307417A (en) A chimeric antigen receptor comprising an anti-HER2 antibody or an antigen-binding fragment thereof and natural killer cells comprising the same
PE20231504A1 (es) Anticuerpos especificos para kras y sus usos
BR112022021077A2 (pt) Anticorpos humanizados antifator bb de complemento e uso dos mesmos
BR112021020677A2 (pt) Anticorpos contra receptores de antígeno quimérico derivados de 4g7
MX2023008028A (es) Anticuerpos anti-pd-l1 y proteinas de fusion de estos.
PE20221902A1 (es) Anticuerpos anti-e-selectina, composiciones y metodos de uso
AR119866A1 (es) Desarrollo de una plataforma de hibridoma eficaz para descubrimiento de anticuerpos terapéuticos
CO2024012915A2 (es) Composiciones de anticuerpo monoclonal anti-c5
CO2023000343A2 (es) Anticuerpos terapéuticos anti-emap ii humanizados
RU2017146315A (ru) Мышиная гибридома ykl-40, клон 2g8 c10 - продуцент моноклонального антитела, обладающего специфичностью к хитиназоподобным белкам ykl-39, ykl-40 и si-clp человека